1993
DOI: 10.1006/geno.1993.1009
|View full text |Cite
|
Sign up to set email alerts
|

Twelve New Polymorphic Microsatellites on Human Chromosome 22

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1993
1993
1999
1999

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…STRP Parental origin and size of the deletion was defined by a set of 10 short tandem repeat polymorphic (STRP) markers (D22S264 [Marineau et al, 1992]; D22S311 and D22S306 [Porter et al, 1993]; D22S427 [Gyapay et al, 1994]; D22S941 and D22S944 ; and D22S1638, D22S1648, D22S1623, and D22S308 [Carlson et al, 1997a] and The Genome Database. The DNA template (∼100 ng) prepared from peripheral blood or fibroblast cultures was used in a 25-l polymerase chain reaction (PCR).…”
Section: Methodsmentioning
confidence: 99%
“…STRP Parental origin and size of the deletion was defined by a set of 10 short tandem repeat polymorphic (STRP) markers (D22S264 [Marineau et al, 1992]; D22S311 and D22S306 [Porter et al, 1993]; D22S427 [Gyapay et al, 1994]; D22S941 and D22S944 ; and D22S1638, D22S1648, D22S1623, and D22S308 [Carlson et al, 1997a] and The Genome Database. The DNA template (∼100 ng) prepared from peripheral blood or fibroblast cultures was used in a 25-l polymerase chain reaction (PCR).…”
Section: Methodsmentioning
confidence: 99%
“…The patient and her parents had been tested before, for the following 10 short-tandem-repeat polymorphism (STRP) markers from the 22q11.2 region: D22S264 (Marineau et al 1992); D22S311 and D22S306 (Porter et al 1993); D22S427 (Gyapay et al 1994); D22S941 and D22S944 (Morrow et al 1995); and D22S1638, D22S1648, D22S1623, and D22S308 (Carlson et al 1997a, Genome Database), as described elsewhere (Rauch et al 1998b). Subsequently, the patient, her sibs, her parents, and her maternal grandparents were tested for STRPs at the loci D22S311 (Genome Database 190609), D22S1709 (Genome Database 5865052), D22S306 (Genome Database 190620), D22S308 (Genome Database 190623), D22S425 (Genome Database 199610), D22S303 (Genome Database 190616), D22S257 (Genome Database 180549), D22S301 (Genome Database 190613), D22S156 (Genome Database 177327), TOP1P2 (Genome Database 159908), D22S1144 (Genome Database 606049; SangerCentre bK929C8), and D22S1167 (Genome Database 610902; Sanger Centre bK373H7), by PCR amplification of DNA extracted from fresh peripheral blood and separation on 6% denaturing polyacrylamide gels (41 cm) in a Li-cor (MWG-Biotech) sequencer, as described elsewhere (Rauch et al 1998b).…”
Section: A Novel 22q112 Microdeletion In Digeorge Syndromementioning
confidence: 99%
“…The patient and her parents had been tested before, for the following 10 short-tandem-repeat polymorphism (STRP) markers from the 22q11.2 region: D22S264 (Marineau et al 1992); D22S311 and D22S306 (Porter et al 1993); D22S427 (Gyapay et al 1994); D22S941 and D22S944 (Morrow et al 1995); and D22S1638, D22S1648, D22S1623, and D22S308 (Carlson et al 1997a, Genome Database), as described elsewhere (Rauch et al 1998b). Subsequently, the patient, her sibs, her parents, and her maternal grandparents were tested for STRPs at the loci D22S311 (Genome Database 190609), D22S1709 (Genome Database 5865052), D22S306 (Genome Database 190620), D22S308 (Genome Database 190623), D22S425 (Genome Database 199610), D22S303 (Genome Database 190616), D22S257 (Genome Database 180549), D22S301 (Genome Database 190613), D22S156 (Genome Database 177327), TOP1P2 (Genome Database 159908), D22S1144 (Genome Database 606049; SangerCentre bK929C8), and D22S1167 (Genome Database 610902; Sanger Centre bK373H7), by PCR amplification of DNA extracted from fresh peripheral blood and separation on 6% denaturing polyacrylamide gels (41 cm) in a Li-cor (MWG-Biotech) sequencer, as described elsewhere (Rauch et al 1998b).…”
Section: A Novel 22q112 Microdeletion In Digeorge Syndromementioning
confidence: 99%